Just a reminder, in January the company mentioned the development of ophthalmic products for SPL7013. Coronavirus common routes to infect people: the lungs, the mouth and the eyes. The eye is the least protected area. An SPL7013 drops would provide an excellent topical protection against airborne cov19 virus. An excellent product, an eue spray for people who are at the front lines.So rethink again, the product is already in development since january.
SPL7013 ophthalmic drops potential
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
12.0¢ |
Change
0.010(9.09%) |
Mkt cap ! $50.17M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 12.0¢ | 11.0¢ | $127.2K | 1.070M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 130918 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 103000 | 3 |
View Market Depth
| Last trade - 16.10pm 19/11/2024 (20 minute delay) ? |
| SPL (ASX) Chart |